Quince Therapeutics ($QNCX) Insider Trading & Smart Money Activity

Quince Therapeutics, Inc. · Biotechnology · Latest filing Jun 24, 2026

Quince Therapeutics, Inc. ($QNCX) has 2 insider trades and 2 analyst ratings on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

2

QNCX insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All QNCX insider, congress, 13F and analyst activity

All Insiders Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 24, 2026	Analyst	Leerink Partners	Reiterates to buy		PT $4		-12.0%	-6.2%			Read
Jun 23, 2026	Analyst	Cantor Fitzgerald	Reiterates to buy		PT $4		-6.0%	-5.6%			Read
Jun 11, 2026	Insider	Christopher Senner	Buy (Grant or award)	2.70K sh			-0.2%	-8.9%			Read
Jun 11, 2026	Insider	David Lamond	Buy (Grant or award)	2.70K sh			-0.2%	-8.9%			Read

1W / 1M / 6M = how QNCX moved from the trade or filing date.

Insider trading in QNCX: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Christopher Senner		1	—		Jun 11, 2026
David Lamond		1	—		Jun 11, 2026

Analyst ratings on QNCX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 24, 2026	Leerink Partners	Reiterates	buy	$4	-12.0%	-6.2%		Read
Jun 23, 2026	Cantor Fitzgerald	Reiterates	buy	$4	-6.0%	-5.6%		Read

Frequently asked questions

What is the latest insider trade in QNCX?

Christopher Senner filed a buy (grant or award) of 2.70K sh on Jun 11, 2026.

Other biotechnology stocks

• $CVM
• $ALGS
• $CNTX
• $IGC
• $CELU
• $NXTC
• $PVCT
• $EDSA

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.